Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

FTSE Lower On RBS, NMC And AstraZeneca

Published 02/14/2020, 04:51 AM
Updated 12/14/2017, 05:25 AM

Negative company news is dragging down the FTSE even as the Chinese virus outbreak is showing signs of containment.

Royal Bank of Scotland (LON:RBS) lost 5.4% in early trading after the majority state-owned banking group reported an increased profit for the fourth quarter but reduced its medium-term returns target.

Shares in the embattled health operator NMC Health (LON:NMC)h also dropped after the vice chair Khalifa Butti Omeir Bin Yousef resigned from his position, only days after the company’s co-founder B.R. Shetty left the board after admitting to potentially inaccurately reporting his holdings in the company.

AstraZeneca (NYSE:AZN) also took a hit in its share price having reported a drop in core operating profits and missing expectations.

Brent crude steadies as Russia decision expected

The slide in Brent crude prices has stopped for the moment and prices seem to have stabilised just above the $56/bbl mark thanks to the slowdown of the spread of the coronavirus in China. A large part of China’s industrial production has come back on line this week or is due to restart over the next three days after several weeks of closures.

OPEC and Russia have yet to come to some agreement over whether the extended producer group will increase its existing production cuts to counter the decline in oil prices. Russia is dragging its feet and even a meeting between the country’s energy minister and main oil producers has not yielded an answer to OPEC’s proposal to reign in production by another 600,000bbl/d.

WTIis also marginally higher, trading close to $51.50.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The pound perked up overnight at the prospect of higher government spending under the new Chancellor of the Exchequer but has since given up about 0.1% against the dollar, settling just above the $1.3 mark.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.